Last update 13 Sep 2025

Glycopyrrolate/OLODATEROL HYDROCHLORIDE

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
mAChRs x β2-adrenergic receptor
Action
antagonists, agonists
Mechanism
mAChRs antagonists(Muscarinic acetylcholine receptor antagonists), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Infectious DiseasesRespiratory Diseases
Active Indication
Bronchitis, ChronicPulmonary Disease, Chronic ObstructivePulmonary Emphysema
Inactive Indication-
Originator Organization
Shanghai Gusen Medical Co., Ltd.Shanghai Gusen Medical Co., Ltd.
Active Organization
Nanchang Gusen Biopharmaceutical Co., Ltd.Shanghai Gusen Medical Co., Ltd.Shanghai Gusen Medical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseIND Approval
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC21H27ClN2O5
InChIKeyKCEHVJZZIGJAAW-FERBBOLQSA-N
CAS Registry869477-96-3
View All Structures (2)

Related

100 Clinical Results associated with Glycopyrrolate/OLODATEROL HYDROCHLORIDE
Login to view more data
100 Translational Medicine associated with Glycopyrrolate/OLODATEROL HYDROCHLORIDE
Login to view more data
100 Patents (Medical) associated with Glycopyrrolate/OLODATEROL HYDROCHLORIDE
Login to view more data
100 Deals associated with Glycopyrrolate/OLODATEROL HYDROCHLORIDE
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bronchitis, ChronicIND Approval
China
Shanghai Gusen Medical Co., Ltd.Shanghai Gusen Medical Co., Ltd.
20 Oct 2022
Pulmonary Disease, Chronic ObstructiveIND Approval
China
Nanchang Gusen Biopharmaceutical Co., Ltd.
20 Oct 2022
Pulmonary EmphysemaIND Approval
China
Shanghai Gusen Medical Co., Ltd.Shanghai Gusen Medical Co., Ltd.
20 Oct 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free